EN | TH

Code of Conduct 

Management Approach 

BDMS commits to conducting fair, transparent and verifiable business operations under good ethics and anti-corruption principle, considering the benefits of all stakeholders from internal and external businesses in Thailand and abroad. Moreover, BDMS supports and governs the executives and all employees by enforcing and announcing the Code of Conduct and related policies such as BDMS Code of Conduct, Fraud Prevention and Anti-Corruption Policy, Whistleblower Policy and Policy on Non-Infringement of Intellectual Property Rights and Copyrights. In addition, BDMS communicates all policies to the executives, Board of Directors and all employees with the intention to set the regulations and work scope under good ethics, corporate governance and integrity as essential principles for business operations.

BDMS Employee Code of Conduct 

Bangkok Dusit Medical Services Public Company Limited (BDMS) and its subsidiaries are committed to conducting business with integrity and achieving corporate objectives in alignment with ethical principles. BDMS ensures that employees at all levels understand and adhere to established guidelines, which serve as the criteria and framework for operations. Upholding the highest standards of integrity, ethics, honesty, and anti-corruption, BDMS is dedicated to fostering a workforce that is both competent and ethically responsible. This commitment is in accordance with good corporate governance practices, as well as all applicable laws and regulations. The BDMS Code of Conduct is outlined as follows:

• Regulatory Compliance 
• Political Engagement 
• Company Assets Protection 
• Confidentiality and Internal Data Usage 
• Conflicts of Interest 
• Giving and Receiving Gifts 
• Self-Conduct and Employee Treatment 
• Fair Competition
• Occupational Health, Safety and Environment

BDMS Fraud Prevention and Anti-Corruption Policy

BDMS establishes the "Fraud Prevention and Anti-Corruption Policy, serving as a guideline with measures to prevent and Anti-corruption measures. The policy specifies the expectations and responsibilities of directors, executives, and employees of BDMS groups and its subsidiaries at all levels. The guidelines cover the action taken to prevent fraud and corruption, including whistleblower mechanism with the following commitments: 

1. Establishing guideline to prevent bribery and corruption, including  

• Establish procurement regulation and contractual arrangements and ensure that the processes are audited by internal audit 
• Guidelines for risk control and prevention measures of charitable giving and public contribution that include acknowledgements of gifts, political contributions and charitable contributions or sponsorship 

2. Corrective or disciplinary actions will be taken in accordance with the Company’s regulations in case of misconduct or non-compliance of the policy 

3. Establishing procedures for handling breaches through complaint /notification channels and responsible persons to be notified in case of any activities leading toward corruption are observed 

4. Ensuring provides training programs relating to anti-bribery and anti-corruption to BDMS employees and external stakeholders. All employees are required to comply with Flow Diagram of Complaint Management for Ethical Related Issues. 

5. Whistleblowing mechanisms are in place, which covering: 

• Establishing dedicated persons and/or departments department(s) responsible for the whistleblowing mechanism 
• The company shall maintain the confidentiality of the whistle-blowers 
• BDMS’s whistle-blower protection includes anonymous reporting 
• BDMS has zero tolerance policy for retaliation. The whistle-blowers are protected against retaliation or any unfavorable treatment against them upon reporting any misconduct or compliance concern. Disciplinary action taken is in place for retaliation on persons who report a misconduct. 
• Provision of training on the use of reporting channel.  

The policies and guidelines regarding to Fraud Prevention and Anti-Corruption are regularly reviewed to ensure compliance with relevant laws, regulations, and rules governing the organization’s business operations and shall be presented to the Board of Directors for approval. 

For more information, please see attached policy: BDMS Fraud Prevention and Anti-Corruption Policy 

BDMS Supplier Code of Conduct

BDMS sets out guidelines and the code of conduct for suppliers to ensure understanding and strengthen relationships with them. Moreover, the process ensures sustainable values for internal and external stakeholders and encourages continuous development throughout the supply chain covering economic, social, environmental, and governance aspects to create transparent, fair, and verifiable business conduct. BDMS monitors supplier performance through an evaluation system to ensure compliance with the Supplier Code of Conduct. The suppliers violating the code of conduct affecting operations in BDMS networks will be taken off the Approved Vendor List (AVL) and excluded from the procurement process.

BDMS Supplier Code of Conduct

Ethical Marketing Commitment

BDMS Ethical Framework Management

BDMS’s Ethical Framework Management adheres to the JCI Standard (8th Edition) on Governance, Leadership, and Direction, and reflects the organization’s strong commitment to responsible marketing and ethical conduct. BDMS is dedicated to providing accurate, balanced, and non-misleading information about its products and services, ensuring ethical interactions with patient groups and healthcare professionals, and maintaining transparency in all contributions and collaborations. Engagements with patient organizations are carried out ethically and transparently, with a clear commitment to preserving their independence. This framework is embedded across our operations to uphold trust, integrity, and accountability. The details are as follows:

 Ethical framework principles:       

1. Put Patients First 

• Optimal Care for All ­ Working as  partners,  at both the individual  and organization level, to ensure  collaboration  between  patients  and  healthcare  professionals  in  supporting  patients  and  their  caregivers in  making  the  best  decision  regarding  their  treatment. 
• Collaboration – All practitioners working  in  healthcare have  right and  responsibility  to collaborate  in improving  healthcare  access  and  delivery.  Establishing  collaboration  will  aim  to  deliver  greater  patient  benefits.
• Promote  the rights of  patients and protect confidentiality  of patient  information. 
• To promote shared decision-making  between patients or their  surrogates if decisional  incapacitated  and  their clinicians. 
• To promote  policies and procedures that maximizes the  likelihood of achieving  good,  patient centered  outcomes, BDMS commits to clearly stating approved health conditions and providing balanced information on the benefits and risks of the medicine.
• Require prior approval of all promotional materials—including BDMS printed and digital content referencing product names, active ingredients, claims, features, or benefits—before distribution or use. These materials must comply with approved product labeling, local laws and regulations, and relevant industry codes, and must be approved by Compliance, Ethics, or a designated regulatory division.
• Require prior approval of all non-promotional materials, including BDMS disease awareness campaigns, health literacy content, and educational information, to ensure alignment with ethical standards, scientific accuracy, and applicable regulatory requirements.
• Require for the review and monitoring of activities, content, and materials on social media and digital channels to ensure compliance with relevant industry codes and applicable laws such as The Consumer Protection Act B.E. 2522 (1979) and Medical Facilities Act, 2541 (1998).

2. Ensure Independence and Ethical Conduct

• Interactions are at  all times ethical,  appropriate  and professional. Business relationships uphold integrity and transparency, while engagement with patient group/organizations remains ethical, transparent, and independent. 
• Establish a mechanism  by which  healthcare  providers and other staff may report clinical errors and   raise ethical concerns with impunity, including  disruptive  staff behavior  related to  clinical and/or operational issues.
• Support an ethical  environment that allows  free  discussion of ethical  concerns without fear of  retribution. 
• Ensure nondiscrimination in  employment practices and provision of patient care in the  context of the cultural  and  regulatory norms of the  country. 

3. Promote Transparency and Accountability

• Disclose ownership and  any conflicts of interest.  
• Honesty  in portraying its services to  patients.  
• Bill accurately for  its  services  and  ensure that  financial  incentives and payment  arrangements do not compromise  patient  care.  
• Provide  an effective and timely resolution  to ethical conflicts that arise.

BDMS Policy Influence Contribution 2021 - 2024